Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 11/14/22
Due: 11/14/23
Phase: N/A
Priority: Normal
Start: 10/22/20
End: 11/14/22
Due: 11/14/23
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 03/10/17
Due: 03/10/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device | NCT04595903 | Aethlon Medical Inc. | user2@example.com | None | 2022-06-01 | 2022-11-14 | 2023-11-14 | - | - | 2025-07-14 |
| Hemopurifier Plus Pembrolizumab in Head and Neck Cancer | NCT04453046 | Aethlon Medical Inc. | user2@example.com | None | 2020-10-22 | 2022-11-14 | 2023-11-14 | - | - | 2025-07-14 |
| Safety Study of the Aethlon Hemopurifier | NCT02215902 | Aethlon Medical Inc. | user2@example.com | None | 2014-12-31 | 2017-03-10 | 2018-03-10 | - | - | 2025-07-14 |